Show simple item record

dc.contributor.authorMEASURE Evaluation
dc.date.accessioned2020-09-07T19:48:24Z
dc.date.available2020-09-07T19:48:24Z
dc.identifier.urihttps://lib.digitalsquare.io/handle/123456789/77346
dc.description.abstractAddressing gender when monitoring and evaluating emerging infectious disease (ID) interventions and programs helps to ensure equity in access and benefits for men and women. This brief explores the importance of gender in monitoring and evaluation (M&E) activities and suggests indicators to reveal and explain gender gaps in emerging ID outcomes.en_US
dc.language.isoen_USen_US
dc.subjectGenderen_US
dc.subjectInfectious diseaseen_US
dc.subjectMonitoringen_US
dc.subjectEvaluationen_US
dc.titleThe Importance of Gender in Emerging Infectious Diseases Dataen_US
dc.typeArticleen_US
dc.date.modified2017


Files in this item

Thumbnail

This item appears in the following Collection(s)

  • Gender and HIS [8]
    Efforts to contain and respond to emerging infectious diseases often divert resources away from routine health services, disproportionately impacting women who seek contraceptives, or maternal health and postnatal care.

Show simple item record

Digital Square is a PATH-led initiative funded and designed by the United States Agency for International Development, the Bill & Melinda Gates Foundation, and a consortium of other donors.

Funders' Logos

This platform is made possible by the generous support of the American people through the United States Agency for International Development (USAID). The contents of this platform are the sole responsibility the respective course developers as noted within the platform, and do not necessarily reflect the views of PATH, USAID, the United States Government, or PATH’s funders.